Advertisement
QIAGEN Ingenuity
QIAGEN Ingenuity

The Scientist

» drug development

Most Recent

image: Pharma's Fake Innovation Crisis?

Pharma's Fake Innovation Crisis?

By | August 13, 2012

Two medical professors contend that the pharmaceutical industry is really suffering from a drive to make only marginal improvements to existing drugs.

2 Comments

image: Cancer Stem Cells Really Do Exist?

Cancer Stem Cells Really Do Exist?

By | August 1, 2012

Researchers track tumors as they develop, providing more support for the idea that cells with stem-cell-like properties underlie cancer growth and recurrence.

4 Comments

image: Lymphatic Lines

Lymphatic Lines

By | August 1, 2012

Lymphatic vessels grow towards two chemokines, revealing signals that could be important in cancer metastasis.

0 Comments

image: Stem Cell Treatment = Drug

Stem Cell Treatment = Drug

By | July 30, 2012

A US federal court rules that procedures in which a patient's own stem cells are extracted, manipulated, and reinjected should be regulated by the FDA.

7 Comments

image: Tissue on Chips Galore

Tissue on Chips Galore

By | July 26, 2012

The National Institutes of Health will fund 17 projects developing lab-on-a-chip applications to improve drug screening.

1 Comment

image: Cancer Drug Flushes Out HIV

Cancer Drug Flushes Out HIV

By | July 26, 2012

An approved cancer therapeutic makes hiding HIV susceptible to antiviral therapy.

1 Comment

image: Europe to Revamp Clinical Trial Rules

Europe to Revamp Clinical Trial Rules

By | July 18, 2012

After years of complaints, the European Commission proposes ways to fix its system in an effort to reinvigorate research on the continent.

1 Comment

image: Withdrawn Sepsis Drug Vindicated

Withdrawn Sepsis Drug Vindicated

By | July 17, 2012

A new study suggests that a drug for blood poisoning that was withdrawn by its manufacturer does work after all.

2 Comments

image: Obama Signs FDA Bill

Obama Signs FDA Bill

By | July 11, 2012

The new law reauthorizes fees charged to drug and device makers, creates new fees for the approval of generic drugs.

0 Comments

image: Pharma Company Sues FDA

Pharma Company Sues FDA

By | July 10, 2012

The maker of a pregnancy medication takes action against the federal agency for not stopping pharmacies from making and selling cheaper versions of the drug.

2 Comments

Popular Now

  1. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  2. First Data from Anti-Aging Gene Therapy
  3. Locating Language within the Brain
  4. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

Advertisement
Diagenode
Diagenode
Advertisement
RayBioTech